| Filed On | Filing |
|---|---|
| 27 Oct 2026 | SCHEDULE 13G |
| 13 Oct 2026 |
Form 4: Bruun Brent C, Director
Sold 662 shares ($4.33K) |
| 24 Aug 2026 |
Form 4: Deckoff Stephen H, Director and 1 other
Received 9,506 shares as a grant or award |
| 24 Aug 2026 |
Form 4: Spytek Joseph Anthony, Director
Acquired 12,548 shares (Other Transaction) |
| 24 Aug 2026 |
Form 4: Kagan David B., Director
Acquired 13,055 shares (Other Transaction) |
| 24 Aug 2026 |
Form 4: Tolley David, Director
Acquired 13,499 shares (Other Transaction) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Jun 2026 |
Form 4: Feingold Felise, SVP General Counsel
Sold 1,862 shares ($14.1K) |
| 12 Jun 2026 |
Form 4: Bruun Brent C, Director
Sold 2,230 shares ($16.9K) |
| 12 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 29 May 2026 |
Form 4: Radoff Bradley Louis, 10% owner and 1 other
Sold 35,000 shares ($392K) |
| 28 May 2026 | SD |
| 06 May 2026 | 10-Q |
| 06 May 2026 | 8-K: Results of Operations and Financial Condition |
| 28 Apr 2026 | ARS |
| 28 Apr 2026 |
Proxy statement: annual meeting on June 10, 2026
CEO pay $1.5M, up 22% · say-on-pay vote |
| 12 Mar 2026 |
Form 4: Feingold Felise, SVP General Counsel
Sold 1,594 shares ($10.6K) |
Loading...